Diet Management of Patients with Chronic Kidney Disease in Bariatric Surgery

Morbid obesity is considered a civilization disease of the 21st century. Not only does obesity increase mortality, but it is also the most important cause of the shortening life expectancy in the modern world. Obesity is associated with many metabolic abnormalities: dyslipidemia, hyperglycemia, cardiovascular diseases, and others. An increasing number of patients diagnosed with chronic kidney disease (CKD) are obese. Numerous additional disorders associated with impaired kidney function make it difficult to conduct slimming therapy and may also be associated with a greater number of complications than in people with normal kidney function. Currently available treatments for obesity include lifestyle modification, pharmacotherapy, and bariatric surgery (BS). There are no precise recommendations on how to reduce excess body weight in patients with CKD treated conservatively, undergoing chronic dialysis, or after kidney transplantation. The aim of this study was to analyze studies on the bariatric treatment of obesity in this group of people, as well as to compare the recommendations typical for bariatrics and CKD.

Automated summary

Morbid obesity is a prevalent disease in the 21st century, contributing to increased mortality and decreased life expectancy. It is associated with various metabolic abnormalities and is particularly prevalent among patients with chronic kidney disease (CKD). The management of obesity in CKD patients presents unique challenges due to the concomitant disorders and complications associated with impaired kidney function. This study aims to analyze the bariatric treatment of obesity in CKD patients and compare the recommendations in bariatrics and CKD management.